Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -8.99% is 35% above its 5-year average of -13.78%, around the middle of its 5-year range (-26.12%–-1.27%).
13.73% below its 12-month average of -7.90%.
Reported quarterly return on assets; no daily interpolation. Q3 FY2026 (2026-07-31): 3.09%.
RETURN ON ASSETS (ROA)
-8.99%
RETURN ON ASSETS (ROA) AVG TTM
-7.90%
RETURN ON ASSETS (ROA) AVG 3Y
-14.69%
RETURN ON ASSETS (ROA) AVG 5Y
-13.78%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-13.73%
CURRENT VS 3Y AVG
+38.81%
CURRENT VS 5Y AVG
+34.78%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.37%
median of 787 covered companies
CURRENT VS SECTOR MEDIAN
+71.34%
vs the sector median at left
High Tide Inc.
Market Cap
$236.81M
Return on Assets (ROA)
-8.99%
TTM Avg
-7.90%
3Y Avg
-14.69%
5Y Avg
-13.78%
Market Cap
$237.41M
Return on Assets (ROA)
-1.57%
TTM Avg
17.43%
3Y Avg
19.75%
5Y Avg
24.82%
Market Cap
$237.27M
Return on Assets (ROA)
-8.48%
TTM Avg
-16.43%
3Y Avg
-20.20%
5Y Avg
-32.31%
Market Cap
$238.61M
Return on Assets (ROA)
-23.88%
TTM Avg
-71.64%
3Y Avg
-51.89%
5Y Avg
-47.09%
Market Cap
$240.34M
Return on Assets (ROA)
-114.79%
TTM Avg
-67.19%
3Y Avg
-63.94%
5Y Avg
-45.91%
Market Cap
$240.52M
Return on Assets (ROA)
-49.04%
TTM Avg
-75.08%
3Y Avg
-74.95%
5Y Avg
-71.96%
Market Cap
$232.96M
Return on Assets (ROA)
-4.22%
TTM Avg
-27.32%
3Y Avg
-24.76%
5Y Avg
-32.27%
Market Cap
$241.78M
Return on Assets (ROA)
-34.55%
TTM Avg
-30.02%
3Y Avg
-24.36%
5Y Avg
-21.40%
Market Cap
$242.02M
Return on Assets (ROA)
-187.80%
TTM Avg
-213.40%
3Y Avg
-188.65%
5Y Avg
-151.14%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| High Tide Inc. (HITI) | $236.81M | -8.99% | -7.90% | -14.69% | -13.78% |
| SIGA Technologies, Inc. (SIGA)vs › | $237.41M | -1.57% | 17.43% | 19.75% | 24.82% |
| Akebia Therapeutics, Inc. (AKBA)vs › | $237.27M | -8.48% | -16.43% | -20.20% | -32.31% |
| InflaRx N.V. (IFRX)vs › | $238.61M | -23.88% | -71.64% | -51.89% | -47.09% |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $240.34M | -114.79% | -67.19% | -63.94% | -45.91% |
| Invivyd, Inc. (IVVD)vs › | $240.52M | -49.04% | -75.08% | -74.95% | -71.96% |
| MacroGenics, Inc. (MGNX)vs › | $232.96M | -4.22% | -27.32% | -24.76% | -32.27% |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $241.78M | -34.55% | -30.02% | -24.36% | -21.40% |
| Galectin Therapeutics Inc. (GALT)vs › | $242.02M | -187.80% | -213.40% | -188.65% | -151.14% |
| Lifecore Biomedical, Inc. (LFCR)vs › | $242.31M | N/A | -14.72% | -16.00% | -18.82% |
ROA
-9.0%
ROE
-31.6%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-10-31 | -14.54% |
| 2024-10-31 | -1.27% |
| 2023-10-31 | -16.84% |
| 2022-10-31 | -26.12% |
| 2021-10-31 | -13.95% |
| 2020-10-31 | -9.98% |
| 2019-10-31 | -64.53% |
| 2018-10-31 | -17.44% |
| 2017-10-31 | 2.67% |
| 2016-10-31 | 11.67% |
